Spots Global Cancer Trial Database for genomic alteration
Every month we try and update this database with for genomic alteration cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas | NCT04750928 | Neurofibromatos... | Abemaciclib | 12 Years - | National Institutes of Health Clinical Center (CC) | |
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials | NCT02534649 | Solid Tumor Hematological M... | Newly obtained ... | 18 Years - | Institut Bergonié | |
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials | NCT02534649 | Solid Tumor Hematological M... | Newly obtained ... | 18 Years - | Institut Bergonié | |
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas | NCT04750928 | Neurofibromatos... | Abemaciclib | 12 Years - | National Institutes of Health Clinical Center (CC) |